Turn Therapeutics Inc. (TTRX) Stock

NASDAQ: TTRXHealthcare company in the biotechnology industry, based in Westlake Village, CA.

Turn Therapeutics stock price chart

TTRX interactive chart →

TTRX stock quote & key statistics

Turn Therapeutics earnings per share

Income →
Earnings per share

Turn Therapeutics revenue & net income

Income →
RevenueNet income

Turn Therapeutics annual financials

Income statement →
Fiscal yearRevenueNet incomeEPS
FY2025$0-$3.2M-$0.11
FY2024$0-$1.8M—
FY2023$0-$2.3M—

Fiscal year ending December 31. Source: company filings via EODHD.

About Turn Therapeutics Inc.

Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.

Turn Therapeutics stock FAQ

What is the Turn Therapeutics stock ticker symbol?

Turn Therapeutics Inc. trades on the NASDAQ under the ticker symbol TTRX.

What sector and industry is Turn Therapeutics in?

Turn Therapeutics Inc. is classified in the Healthcare sector, Biotechnology industry.

How many employees does Turn Therapeutics have?

Turn Therapeutics Inc. has about 2 full-time employees.

What were Turn Therapeutics's revenue and earnings last fiscal year?

Turn Therapeutics reported revenue of $0 and net income of -$3.2M in fiscal 2025, with earnings per share of -$0.11.

When did Turn Therapeutics go public?

Turn Therapeutics stock began trading on October 8, 2025.

Biotechnology stocks

All Healthcare stocks →